Understanding country-specific development of immunization programs is essential for their successful implementation.
As part of assessing the market opportunity for a vaccine, it is crucial to understand how countries translate new evidence for vaccines into favorable vaccine recommendations and what country-specific concerns/constraints may impede access.
Our client, a leading vaccine company, was looking for help to assess the market opportunity and policy developments for a maternal immunization across different countries.
Our team conducted a comprehensive assessment of the value drivers and barriers that influence vaccine recommendations through validation of internal hypotheses with relevant country-specific stakeholders.
First, we identified the value drivers for markets that have recently recommended a vaccine program and assessed barriers to recommendations in markets that do not recommend maternal vaccination.
Second, we pressure-tested our understanding of the triggers of recommendation decision-making and timing of inclusion in future immunization programs through one-on-one interviews with ex-policy makers and physicians.
We provided strategic guidance to increase the likelihood of a favorable vaccine recommendation by national immunization bodies.
For each country, we developed a stakeholder map for vaccine recommendation decisions and identified critical triggers for positive and negative immunization recommendation outcomes.
Our experts are always happy to discuss your issue. Reach out, and we’ll connect you with a member of our team.